PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 1 month ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year 1 month ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 2 months ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year 2 months ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 1 year 3 months ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 1 year 3 months ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 3 months ago EQS-Adhoc: BB Biotech AG publishes its 2024 annual report BB Biotech AG publishes its 2024 annual report, revealing financial performance and proposed dividend. Report includes biotech sector overview and investment details Biotechnology Investment Dividend BB Biotech AG 2024 Annual Report
PRESS RELEASE published on 02/21/2025 at 07:00, 1 year 3 months ago Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics BB Biotech's 2024 Annual Report highlights the company's strategic positioning for sector recovery amid shifting market dynamics, including key milestones and financial results Annual Report Investment Performance Sector Recovery Market Dynamics BB Biotech
BRIEF published on 01/24/2025 at 07:05, 1 year 4 months ago BB Biotech: 2024 Results and Dividend Proposal Overview Dividend Proposal Biotech Sector BB Biotech Investor Sentiment 2024 Results
BRIEF published on 01/24/2025 at 07:05, 1 year 4 months ago BB Biotech AG Reports Profit in 2024 Fiscal Year Financial Results Investment Performance BB Biotech AG 2024 Fiscal Profit Drug Developers
Published on 06/19/2026 at 00:00, 24 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/18/2026 at 23:55, 29 minutes ago Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member
Published on 06/18/2026 at 23:30, 54 minutes ago American Critical Minerals Extends Early Warrant Exercise Incentive Program
Published on 06/18/2026 at 23:00, 1 hour 24 minutes ago Jaguar Mining Inc. Annual General Meeting of Shareholders Voting Results
Published on 06/18/2026 at 18:00, 6 hours 24 minutes ago BEACN Closes Second Series Under Loan Program and Previews BEACN App Version 1.4
Published on 06/18/2026 at 22:35, 1 hour 49 minutes ago Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 22:00, 2 hours 24 minutes ago Blue Cap AG: Closing of the Acquisition of Janoschka AG Successfully Completed
Published on 06/18/2026 at 18:30, 5 hours 54 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/18/2026 at 18:00, 6 hours 24 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 6 hours 39 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 6 hours 46 minutes ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 09:06, 15 hours 18 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
